Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al

Detalles Bibliográficos
Autores principales: Weber, Jeffrey, Mandala, Mario, Ascierto, Paolo Antonio, Larkin, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768934/
https://www.ncbi.nlm.nih.gov/pubmed/35042825
http://dx.doi.org/10.1136/jitc-2021-004347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768934/
https://www.ncbi.nlm.nih.gov/pubmed/35042825
http://dx.doi.org/10.1136/jitc-2021-004347

Ejemplares similares